6 May 2014 - Deborah Wilkes
Archived
Bayer has agreed to acquire US-based Merck & Co's Consumer Care business for US$14.2 billion in cash. In addition to a portfolio of strong OTC brands – led by the allergy remedy Claritin (loratadine) – the deal includes the global trademark and prescription rights to Claritin and the nasal decongestant Afrin (oxymetazoline).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.